AN2 Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that the company ...

Multiple Subgroup Analyses Presented From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan), Including Data on Lipid an ...

The University of Nevada, Reno’s NevadaTeach program cohosted the annual UTeach STEM Educators Conference on May 20-22.

“The resilience of nuclear installations can be viewed as the ability of the installation to quickly return to its original safety state after the occurrence of a potentially damaging event such as an ...

TAIPEI (Taiwan News) — Taiwan is hosting the prestigious International Particle Accelerator Conference (IPAC) for the first ...

LUND, SE / ACCESS Newswire / June 3, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announced that biomarker data ...

But according to the National Synchrotron Radiation Research Center (NSRRC), a nonprofit research institute funded by the ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, was featured in a poster ...

Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing the investigational therapy Haduviotm (oral nalbuphine ER) for the treatment of chronic cough in patients with ...

Data presented by Delix Therapeutics at the 2025 American Society of Clinical Psychopharmacology (ASCP) Conference confirms the NeuLogiq® Platform is effective at detecting a pharmacodynamic ...

The department of biochemistry, Father Muller Medical College, Kankanady, hosted the inauguration of the 10th annual state ...